# US 2008/0305094 A1 · Nutritional Composition for Improving Skin Condition and Preventing Skin Diseases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0305094 A1
- Document ID: US20080305094A1
- Status: Published application
- Kind: A1
- Application number: 10/597,436
- Filed: 2005-01-27
- Published: 2008-12-11
- Earliest claimed: 2004-01-28
- Assignees: Nestec S.A.
- Inventors: Sylvie Pridmore-Merten
- Web page: https://patentgrep.com/patent/US20080305094A1

## CPC

- A61K 31/375: Ascorbic acid, i.e. vitamin C; Salts thereof
- A23L 33/115: Fatty acids or derivatives thereof; Fats or oils
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/205: Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A61K 31/355: Tocopherols, e.g. vitamin E
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/04: Antipruritics
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The present invention pertains to the use of an ingestable composition containing L-carnitine and at least one component having an anti-oxidative activity for stimulating the lipid metabolism in the skin of an individual, which results in an improvement of the general condition of the skin in particular dry, sensible or reactive skin, and in prevention of the occurrence of skin diseases, such as dermatitis. In addition thereto, the present invention pertains also to the use of such a composition for the preparation of a pharmaceutical composition or of a food, in particular a functional food or petfood product, for increasing lipid secretion in sebum, producing a protective sebum layer on the skin.

## Claims

### Claim 1

A method for the stimulation of the lipid metabolism in the skin of an animal or a human being for treating dermatitis comprising administering an ingestible composition comprising L-carnitine and at least one component having an anti-oxidate activity to a patient in need of same.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the composition increases the lipid secretion in the sebum and/or for producing a protective sebum layer on the skin.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the patient has ulcerative dermatitis.

### Claim 4

A method for the stimulation of the lipid metabolism in the skin of an animal or a human for preventing the onset or incidence of ulcers associated with diabetes, of circulation disturbances, of physical, chemical or microbial noxae or of eczema, comprising the steps of administering to a patient at risk of ulcers an ingestible composition comprising L-carnitine and a component having an anti-oxidative activity.

### Claim 5

A method for the stimulation of the lipid metabolism in the skin of an animal or a human being for a reduction of itching comprising the steps of administering to a patient that is itching due to a skin condition an ingestible composition comprising L-carnitine and a component having anti-oxidative activity.

### Claim 6

A method for making an ingestable composition for the stimulation of the lipid metabolism in the skin of an animal or a human being, comprising the step of using L-carnitine and at least one component having anti-oxidative activity to make the composition.

### Claim 7 (depends on 6)

The method according to claim 6, for producing a protective sebum layer on the skin.

### Claim 8 (depends on 6)

The method according to claim 6 for reducing dry skin or itching.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the component exhibiting an anti-oxidative activity is selected from the group consisting of vitamin E; vitamin C; carotenoids; ubiquinones; tea catechins; coffee extracts containing polyphenols and/or diterpenes; ginkgo biloba extracts; grape or grape seed extracts rich in proanthocyanidins; spice extracts; soy extracts containing isoflavones, phytoestrogens; ursodeoxycholic acid; ursolic acid; ginseng and gingenosides and natural sources thereof; a source of thiols, preferably lipoic acid, cysteine, cystine, methionine, S-adenosyl-methionine, taurine, glutathione or natural sources thereof; or mixtures thereof.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the amount of L-carnitine administered daily is from 1 mg to 1 g per kg of body weight/day.

### Claim 11 (depends on 1)

The method according to claim 1 wherein the amount of the component having an anti-oxidative activity is from 0.025 mg to 250 mg per kg of body weight/day.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the ingestable composition contains a source of fat.

### Claim 13 (depends on 12)

The method according to claim 12, wherein the fat comprises alpha-linolenic acid.

### Claim 14 (depends on 12)

The method according to claim 12, wherein said source of fat is selected from the group consisting of an animal fat, and a vegetable fat.

### Claim 15 (depends on 12)

The method according to claim 12, wherein the amount of said source of fat in the composition is at least 0.1% by weight on basis of the total weight of the composition.

### Claim 16 (depends on 1)

The method according to claim 1, wherein the ingestable composition is selected from the group consisting of a medicament, a food, a functional food, a nutritionally complete pet or human food and a dietary supplement.

### Claim 17

A method for the stimulation of the lipid metabolism in the skin of an animal or a human being comprising the step of administering a composition comprising L-carnitine and at least a component having an anti-oxidative activity and being selected from the group consisting of ubiquinones; tea catechins; coffee extracts containing polyphenols and/or diterpenes; ginkgo biloba extracts; grape or grape seed extracts rich in proanthocyanidins; spice extracts; soy extracts containing isoflavones, phytoestrogens; ursodeoxycholic acid; ursolic acid; ginseng and gingenosides and natural sources thereof; cysteine, cystine, methionine, S-adenosyl-methionine, taurine or natural sources thereof; or mixtures thereof; or being selected from the group of mixtures of vitamin E or derivatives thereof with two or three of vitamin C or derivatives thereof; grape seed extract; and cysteine,
said ingestable composition being a food or a functional food, a nutritionally complete pet or human food or a dietary supplement.

### Claim 18

An ingestable composition selected from the group consisting of a medicament, a food, a functional food, a nutritional complete pet or human food, and a dietary supplement comprising L-carnitine and a least a component having an anti-oxidative activity and being selected from the group consisting of ubiquinones; tea catechins; coffee extracts containing polyphenols and/or diterpenes; ginkgo biloba extracts; grape or grape seed extracts rich in proanthocyanidins; spice extracts; soy extracts containing isoflavones, phytoestrogens; ursodeoxycholic acid; ursolic acid; ginseng and gingenosides and natural sources thereof; cysteine, cystine, methionine, S-adenosyl-methionine, taurine or natural sources thereof; or mixtures thereof; or being selected from the group of mixtures of vitamin E or derivatives thereof with two or three of vitamin C or derivatives thereof; grape seed extract; and cysteine.

### Claim 19 (depends on 4)

The method according to claim 4, wherein the component exhibiting an anti-oxidative activity is selected from the group consisting of vitamin E; vitamin C; carotenoids; ubiquinones; tea catechins; coffee extracts containing polyphenols and/or diterpenes; ginkgo biloba extracts; grape or grape seed extracts rich in proanthocyanidins; spice extracts; soy extracts containing isoflavones, phytoestrogens; ursodeoxycholic acid; ursolic acid; ginseng and gingenosides and natural sources thereof; a source of thiols, preferably lipoic acid, cysteine, cystine, methionine, S-adenosyl-methionine, taurine, glutathione or natural sources thereof; or mixtures thereof.

### Claim 20 (depends on 5)

The method according to claim 5, wherein the component exhibiting an anti-oxidative activity is selected from the group consisting of vitamin E; vitamin C; carotenoids; ubiquinones; tea catechins; coffee extracts containing polyphenols and/or diterpenes; ginkgo biloba extracts; grape or grape seed extracts rich in proanthocyanidins; spice extracts; soy extracts containing isoflavones, phytoestrogens; ursodeoxycholic acid; ursolic acid; ginseng and gingenosides and natural sources thereof; a source of thiols, preferably lipoic acid, cysteine, cystine, methionine, S-adenosyl-methionine, taurine, glutathione or natural sources thereof; or mixtures thereof.

### Claim 21 (depends on 6)

The method according to claim 6, wherein the component exhibiting an anti-oxidative activity is selected from the group consisting of vitamin E; vitamin C; carotenoids; ubiquinones; tea catechins; coffee extracts containing polyphenols and/or diterpenes; ginkgo biloba extracts; grape or grape seed extracts rich in proanthocyanidins; spice extracts; soy extracts containing isoflavones, phytoestrogens; ursodeoxycholic acid; ursolic acid; ginseng and gingenosides and natural sources thereof; a source of thiols, preferably lipoic acid, cysteine, cystine, methionine, S-adenosyl-methionine, taurine, glutathione or natural sources thereof; or mixtures thereof.

### Claim 22 (depends on 9)

The method according to claim 9, wherein the component exhibiting an anti-oxidative activity is selected from the group consisting of vitamin E; vitamin C; carotenoids; ubiquinones; tea catechins; coffee extracts containing polyphenols and/or diterpenes; ginkgo biloba extracts; grape or grape seed extracts rich in proanthocyanidins; spice extracts; soy extracts containing isoflavones, phytoestrogens; ursodeoxycholic acid; ursolic acid; ginseng and gingenosides and natural sources thereof; a source of thiols, preferably lipoic acid, cysteine, cystine, methionine, S-adenosyl-methionine, taurine, glutathione or natural sources thereof; or mixtures thereof.

### Claim 23 (depends on 4)

The method according to claim 4, wherein the amount of L-carnitine administered daily is from 1 mg to 1 g per kg of body weight/day.

### Claim 24 (depends on 5)

The method according to claim 5, wherein the amount of L-carnitine administered daily is from 1 mg to 1 g per kg of body weight/day.

### Claim 25 (depends on 6)

The method according to claim 6, wherein the amount of L-carnitine administered daily is from 1 mg to 1 g per kg of body weight/day.

### Claim 26 (depends on 9)

The method according to claim 9, wherein the amount of L-carnitine administered daily is from 1 mg to 1 g per kg of body weight/day.

### Claim 27 (depends on 4)

The method according to claim 4 wherein the amount of the component having an anti-oxidative activity is from 0.025 mg to 250 mg per kg of body weight/day.

### Claim 28 (depends on 5)

The method according to claim 5 wherein the amount of the component having an anti-oxidative activity is from 0.025 mg to 250 mg per kg of body weight/day.

### Claim 29 (depends on 6)

The method according to claim 6 wherein the amount of the component having an anti-oxidative activity is from 0.025 mg to 250 mg per kg of body weight/day.

### Claim 30 (depends on 9)

The method according to claim 9 wherein the amount of the component having an anti-oxidative activity is from 0.025 mg to 250 mg per kg of body weight/day.

### Claim 31 (depends on 4)

The method according to claim 4, wherein the ingestable composition contains a source of fat.

### Claim 32 (depends on 5)

The method according to claim 5, wherein the ingestable composition contains a source of fat.

### Claim 33 (depends on 6)

The method according to claim 6, wherein the ingestable composition contains a source of fat.

### Claim 34 (depends on 9)

The method according to claim 9, wherein the ingestable composition contains a source of fat.

### Claim 35 (depends on 4)

The method according to claim 4, wherein the ingestable composition is selected from the group consisting of a medicament, a food, a functional food, a nutritionally complete pet or human food and a dietary supplement.

### Claim 36 (depends on 5)

The method according to claim 5, wherein the ingestable composition is selected from the group consisting of a medicament, a food, a functional food, a nutritionally complete pet or human food and a dietary supplement.

### Claim 37 (depends on 6)

The method according to claim 6, wherein the ingestable composition is selected from the group consisting of a medicament, a food, a functional food, a nutritionally complete pet or human food and a dietary supplement.

### Claim 38 (depends on 9)

The method according to claim 9, wherein the ingestable composition is selected from the group consisting of a medicament, a food, a functional food, a nutritionally complete pet or human food and a dietary supplement.
